title: Medical treatment for thyroid-associated ophthalmopathy.
abstract: The medical management of thyroid-associated ophthalmopathy has been, and remains a clinical challenge. Several drugs have been used. Systemic steroids seem to be beneficial in patients with active disease. The evidence for the remaining drugs reported to be potentially useful, is unconvincing.
authors.affiliation: Department of Endocrinology, University of Newcastle upon Tyne, United Kingdom. Petros.Perros@ncl.ac.uk
authors.forename: Petros
authors.initials: P
authors.lastname: Perros
authors.forename: Pat
authors.initials: P
authors.lastname: Kendall-Taylor
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy; D013256:Steroids
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D013256:Steroids